2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)

Teleosis Institute
Teleosis Institute
16 Dec 2010••
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)
1 sur 10

2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)

16 Dec 2010••

by Ilene Ruhoy This slidecast is part of the GreenPharmEdu.org program

Teleosis Institute
Teleosis Institute

Recommandé

ERHS220 posterERHS220 poster
ERHS220 posterWilliam Pelland85 vues•1 diapositive
2.3. Evidence for Ecotoxicity (Ruhoy)2.3. Evidence for Ecotoxicity (Ruhoy)
2.3. Evidence for Ecotoxicity (Ruhoy)Teleosis Institute290 vues•12 diapositives
Why pick on pharmaceuticals as an environmental "problem"(setac basle 2014)Why pick on pharmaceuticals as an environmental "problem"(setac basle 2014)
Why pick on pharmaceuticals as an environmental "problem"(setac basle 2014)David Taylor951 vues•22 diapositives
Emerging pollutants from health establishments - Martin CormicanEmerging pollutants from health establishments - Martin Cormican
Emerging pollutants from health establishments - Martin CormicanEnvironmental Protection Agency, Ireland1.1K vues•44 diapositives
Emerging contaminants in surface and Drainage Water By ShivEmerging contaminants in surface and Drainage Water By Shiv
Emerging contaminants in surface and Drainage Water By ShivTushar Dholakia1.9K vues•38 diapositives
ECOPHARMACOVIGILANCEECOPHARMACOVIGILANCE
ECOPHARMACOVIGILANCEDr Amit Mittal2.7K vues•33 diapositives

Contenu connexe

Tendances

Career Environmental ToxicologistCareer Environmental Toxicologist
Career Environmental ToxicologistUniversity of Richmond - Environmental Studies3.3K vues•25 diapositives
EcopharmacologyEcopharmacology
EcopharmacologyVasanth Sandha1.4K vues•5 diapositives
Drug pollution or pharmaceutical pollutionDrug pollution or pharmaceutical pollution
Drug pollution or pharmaceutical pollutionSmawi GH10.4K vues•17 diapositives
Setting the scene - Laurent MoulinSetting the scene - Laurent Moulin
Setting the scene - Laurent MoulinOECD Environment1.3K vues•10 diapositives
PPCP’s and Their Impact on Our EnvironmentPPCP’s and Their Impact on Our Environment
PPCP’s and Their Impact on Our EnvironmentCori LeBerth610 vues•19 diapositives
Environmental Impact of PharmaceuticalsEnvironmental Impact of Pharmaceuticals
Environmental Impact of PharmaceuticalsState of Utah, Salt Lake City5.1K vues•25 diapositives

Tendances(18)

Career Environmental ToxicologistCareer Environmental Toxicologist
Career Environmental Toxicologist
University of Richmond - Environmental Studies•3.3K vues
EcopharmacologyEcopharmacology
Ecopharmacology
Vasanth Sandha•1.4K vues
Drug pollution or pharmaceutical pollutionDrug pollution or pharmaceutical pollution
Drug pollution or pharmaceutical pollution
Smawi GH•10.4K vues
Setting the scene - Laurent MoulinSetting the scene - Laurent Moulin
Setting the scene - Laurent Moulin
OECD Environment•1.3K vues
PPCP’s and Their Impact on Our EnvironmentPPCP’s and Their Impact on Our Environment
PPCP’s and Their Impact on Our Environment
Cori LeBerth•610 vues
Environmental Impact of PharmaceuticalsEnvironmental Impact of Pharmaceuticals
Environmental Impact of Pharmaceuticals
State of Utah, Salt Lake City•5.1K vues
EcopharmacologyEcopharmacology
Ecopharmacology
Dr Sajeena Jose•832 vues
Contamination primer trabajo de la tercera unidadContamination primer trabajo de la tercera unidad
Contamination primer trabajo de la tercera unidad
Francisco Javier Jimenez Armas•133 vues
JBRM2012JBRM2012
JBRM2012
Chew Khun Tan•75 vues
Emerging Contaminant Threats and the Great LakesEmerging Contaminant Threats and the Great Lakes
Emerging Contaminant Threats and the Great Lakes
Healthy Lakes, Healthy Lives•760 vues
Nutrient economics-report-2015Nutrient economics-report-2015
Nutrient economics-report-2015
walled ashwah•640 vues
Session one- Mr. Nick HaighSession one- Mr. Nick Haigh
Session one- Mr. Nick Haigh
OECD Environment•1.4K vues
Emerging contaminants and precautionary principleEmerging contaminants and precautionary principle
Emerging contaminants and precautionary principle
OdgToscana•2K vues
Session 2- Bruno TisserandSession 2- Bruno Tisserand
Session 2- Bruno Tisserand
OECD Environment•1.4K vues
Environmental PharmacologyEnvironmental Pharmacology
Environmental Pharmacology
Dr. Shivesh Gupta•3.5K vues
Biomarkers for environmental toxicologyBiomarkers for environmental toxicology
Biomarkers for environmental toxicology
Anas Ansari•5.5K vues
Setting the scene - Thomas BackhausSetting the scene - Thomas Backhaus
Setting the scene - Thomas Backhaus
OECD Environment•1.9K vues
Environmental toxicologyEnvironmental toxicology
Environmental toxicology
Ahmed-Refat Refat•4.7K vues

Similaire à 2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)

2.5. PharmEcoVigilance (Ruhoy)2.5. PharmEcoVigilance (Ruhoy)
2.5. PharmEcoVigilance (Ruhoy)Teleosis Institute266 vues•14 diapositives
Comparison of Pharmacology and ToxicologyComparison of Pharmacology and Toxicology
Comparison of Pharmacology and Toxicologyshabeel pn7.5K vues•25 diapositives
Chemicals from the Practice of Healthcare - Challenges & Unknowns Posed by Re...Chemicals from the Practice of Healthcare - Challenges & Unknowns Posed by Re...
Chemicals from the Practice of Healthcare - Challenges & Unknowns Posed by Re...v2zq652 vues•16 diapositives
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)Teleosis Institute349 vues•7 diapositives
2.4. Environmental Impact of Disposal (Ruhoy)2.4. Environmental Impact of Disposal (Ruhoy)
2.4. Environmental Impact of Disposal (Ruhoy)Teleosis Institute434 vues•11 diapositives
839839
839nreferat40 vues•6 diapositives

Similaire à 2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)(20)

2.5. PharmEcoVigilance (Ruhoy)2.5. PharmEcoVigilance (Ruhoy)
2.5. PharmEcoVigilance (Ruhoy)
Teleosis Institute•266 vues
Comparison of Pharmacology and ToxicologyComparison of Pharmacology and Toxicology
Comparison of Pharmacology and Toxicology
shabeel pn•7.5K vues
Chemicals from the Practice of Healthcare - Challenges & Unknowns Posed by Re...Chemicals from the Practice of Healthcare - Challenges & Unknowns Posed by Re...
Chemicals from the Practice of Healthcare - Challenges & Unknowns Posed by Re...
v2zq•652 vues
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)
2.6. Reducing Unused Pharmaceuticals: Conclusion (Ruhoy)
Teleosis Institute•349 vues
2.4. Environmental Impact of Disposal (Ruhoy)2.4. Environmental Impact of Disposal (Ruhoy)
2.4. Environmental Impact of Disposal (Ruhoy)
Teleosis Institute•434 vues
839839
839
nreferat•40 vues
4 5 principle and scope4 5 principle and scope
4 5 principle and scope
MuhammadImranulhaq3•12 vues
Chemical Risk Assessment Traditional vs PublicHealth PerspeChemical Risk Assessment Traditional vs PublicHealth Perspe
Chemical Risk Assessment Traditional vs PublicHealth Perspe
JinElias52•2 vues
introtox-020909.pdfintrotox-020909.pdf
introtox-020909.pdf
AtiqaLiaqat•5 vues
Toxicity studyToxicity study
Toxicity study
indranil chatterjee•1.9K vues
Bearing the Burden - Health Implications of Environmental Pollutants in Our B...Bearing the Burden - Health Implications of Environmental Pollutants in Our B...
Bearing the Burden - Health Implications of Environmental Pollutants in Our B...
v2zq•326 vues
Spokane River Health Consultation 2011Spokane River Health Consultation 2011
Spokane River Health Consultation 2011
Bart Mihailovich•1K vues
CSMT 442 Cost and Estimating 2 Homework 2 `Siteworks CSMT 442 Cost and Estimating 2 Homework 2 `Siteworks
CSMT 442 Cost and Estimating 2 Homework 2 `Siteworks
MargaritoWhitt221•4 vues
Professor Michael Depledge, EPA, HSE and ESRI, Environment, Health and Wellbe...Professor Michael Depledge, EPA, HSE and ESRI, Environment, Health and Wellbe...
Professor Michael Depledge, EPA, HSE and ESRI, Environment, Health and Wellbe...
Environmental Protection Agency, Ireland•116 vues
1051.pdf1051.pdf
1051.pdf
SathiyarajSrinivasan1•53 vues
Chemical influenceChemical influence
Chemical influence
Haroldas Čerkevičius•224 vues
Ecotoxicology-Study aspectsEcotoxicology-Study aspects
Ecotoxicology-Study aspects
ijtsrd•77 vues
toxicokinetics-1.pptxtoxicokinetics-1.pptx
toxicokinetics-1.pptx
Unnatikhare1•36 vues
Discriptive toxicologyDiscriptive toxicology
Discriptive toxicology
Dnyaneshwari Pande•4.8K vues
Regulatory complexities in hp drugsRegulatory complexities in hp drugs
Regulatory complexities in hp drugs
Bhaswat Chakraborty•2.6K vues

Plus de Teleosis Institute

3.5. Facts About Disposal in the U.S. (Kreisberg)3.5. Facts About Disposal in the U.S. (Kreisberg)
3.5. Facts About Disposal in the U.S. (Kreisberg)Teleosis Institute258 vues•22 diapositives
3.4. What is Accumulating & How Do We Know? (Kreisberg)3.4. What is Accumulating & How Do We Know? (Kreisberg)
3.4. What is Accumulating & How Do We Know? (Kreisberg)Teleosis Institute293 vues•31 diapositives
3.3. The Reality of Non-Compliance3.3. The Reality of Non-Compliance
3.3. The Reality of Non-ComplianceTeleosis Institute921 vues•16 diapositives
3.2. Life Cycle Dynamics (Kreisberg)3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)Teleosis Institute267 vues•10 diapositives
3.1. Introduction (Kreisberg)3.1. Introduction (Kreisberg)
3.1. Introduction (Kreisberg)Teleosis Institute579 vues•11 diapositives
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)Teleosis Institute510 vues•18 diapositives

Plus de Teleosis Institute(13)

3.5. Facts About Disposal in the U.S. (Kreisberg)3.5. Facts About Disposal in the U.S. (Kreisberg)
3.5. Facts About Disposal in the U.S. (Kreisberg)
Teleosis Institute•258 vues
3.4. What is Accumulating & How Do We Know? (Kreisberg)3.4. What is Accumulating & How Do We Know? (Kreisberg)
3.4. What is Accumulating & How Do We Know? (Kreisberg)
Teleosis Institute•293 vues
3.3. The Reality of Non-Compliance3.3. The Reality of Non-Compliance
3.3. The Reality of Non-Compliance
Teleosis Institute•921 vues
3.2. Life Cycle Dynamics (Kreisberg)3.2. Life Cycle Dynamics (Kreisberg)
3.2. Life Cycle Dynamics (Kreisberg)
Teleosis Institute•267 vues
3.1. Introduction (Kreisberg)3.1. Introduction (Kreisberg)
3.1. Introduction (Kreisberg)
Teleosis Institute•579 vues
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)
3.6. Reducing Pharmaceutical Waste in Clinical Care (Kreisberg)
Teleosis Institute•510 vues
5.5. State Regulations and Guidance (Batz)5.5. State Regulations and Guidance (Batz)
5.5. State Regulations and Guidance (Batz)
Teleosis Institute•189 vues
5.4. Federal Regulations (Batz)5.4. Federal Regulations (Batz)
5.4. Federal Regulations (Batz)
Teleosis Institute•218 vues
5.3. Methods of Disposal (Batz)5.3. Methods of Disposal (Batz)
5.3. Methods of Disposal (Batz)
Teleosis Institute•785 vues
5.2. Reason for Concern (Batz)5.2. Reason for Concern (Batz)
5.2. Reason for Concern (Batz)
Teleosis Institute•356 vues
5.6. Conclusion (Batz)5.6. Conclusion (Batz)
5.6. Conclusion (Batz)
Teleosis Institute•428 vues
5.1. Introduction (Batz)5.1. Introduction (Batz)
5.1. Introduction (Batz)
Teleosis Institute•194 vues
2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...
2.1. Pharmaceutical in the Environment: An Evidence-based Review: Introductio...
Teleosis Institute•377 vues

2.2. Significance of Long-Term Exposure to Multiple APIs (Ruhoy)